Blood parameters in pediatric myelin oligodendrocyte glycoprotein antibody-associated disorders
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: European Journal of Paediatric Neurology, 50, S. 86-95
- Ereignis
-
Veröffentlichung
- (wo)
-
Augsburg
- (wer)
-
Universität Augsburg
- (wann)
-
2024
- Ereignis
-
Veröffentlichung
- (wer)
-
Elsevier BV
- (wann)
-
2024
- Urheber
-
Peternell, Alina
Lechner, Christian
Breu, Markus
Preisel, Martin
Schimmel, Mareike
Eisenkölbl, Astrid
Zobel, Joachim
Wendel, Eva-Maria
Reindl, Markus
Rostásy, Kevin
Baumann, Matthias
- DOI
-
10.1016/j.ejpn.2024.04.011
- URN
-
urn:nbn:de:bvb:384-opus4-1127679
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
25.03.2025, 13:54 MEZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Peternell, Alina
- Lechner, Christian
- Breu, Markus
- Preisel, Martin
- Schimmel, Mareike
- Eisenkölbl, Astrid
- Zobel, Joachim
- Wendel, Eva-Maria
- Reindl, Markus
- Rostásy, Kevin
- Baumann, Matthias
- Universität Augsburg
- Elsevier BV
Entstanden
- 2024
Ähnliche Objekte (12)
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Features of myelin oligodendrocyte glycoprotein (MOG) required for the detection of autoantibodies from patients with MOG-antibody-associated disorders
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders: Identification of MOG-specific B cells and analysis of the pathogenic potential of MOG antibodies
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients
T-cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice experimental autoimmune encephalomyelitis
Serum neurofilament light-chain levels in children with monophasic myelin oligodendrocyte glycoprotein-associated disease, multiple sclerosis, and other acquired demyelinating syndrome
Röntgenstrukturanalyse des Myelin-Oligodendrocyte-Glycoprotein und seines Komplexes mit dem (8-18C5)-Fab und Röntgenstrukturanalyse der 12-Oxophytodiensäurereduktasen 1 und 3
In vivo approach to myelin turnover and oligodendrocyte-dependent axonal integrity
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Features of myelin oligodendrocyte glycoprotein (MOG) required for the detection of autoantibodies from patients with MOG-antibody-associated disorders
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders: Identification of MOG-specific B cells and analysis of the pathogenic potential of MOG antibodies
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients
T-cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice experimental autoimmune encephalomyelitis
Serum neurofilament light-chain levels in children with monophasic myelin oligodendrocyte glycoprotein-associated disease, multiple sclerosis, and other acquired demyelinating syndrome
Röntgenstrukturanalyse des Myelin-Oligodendrocyte-Glycoprotein und seines Komplexes mit dem (8-18C5)-Fab und Röntgenstrukturanalyse der 12-Oxophytodiensäurereduktasen 1 und 3
In vivo approach to myelin turnover and oligodendrocyte-dependent axonal integrity
Autoimmunity against oligodendrocyte myelin glycoprotein (OMGP)
Visual field loss and structure-function relationships in optic neuritis associated with myelin oligodendrocyte glycoprotein antibody
MRI of the first event in pediatric acquired demyelinating syndromes with antibodies to myelin oligodendrocyte glycoprotein
Features of myelin oligodendrocyte glycoprotein (MOG) required for the detection of autoantibodies from patients with MOG-antibody-associated disorders
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Aspects of immunobiology of myelin oligodendrocyte glycoprotein (MOG) induced experimental autoimmune encephalomyelitis (EAE)
Myelin oligodendrocyte glycoprotein (MOG) antibody associated disorders: Identification of MOG-specific B cells and analysis of the pathogenic potential of MOG antibodies
Cerebrospinal fluid findings in patients with myelin oligodendrocyte glycoprotein (MOG) antibodies. Part 2: results from 108 lumbar punctures in 80 pediatric patients
T-cell epitope spreading to myelin oligodendrocyte glycoprotein in HLA-DR4 transgenic mice experimental autoimmune encephalomyelitis
Serum neurofilament light-chain levels in children with monophasic myelin oligodendrocyte glycoprotein-associated disease, multiple sclerosis, and other acquired demyelinating syndrome
Röntgenstrukturanalyse des Myelin-Oligodendrocyte-Glycoprotein und seines Komplexes mit dem (8-18C5)-Fab und Röntgenstrukturanalyse der 12-Oxophytodiensäurereduktasen 1 und 3